Search - tctmd.com

Displaying 281 - 300 of 771

Sort: Relevancy | Date

News Conference News EAS 2021

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

Michael O'Riordan

June 07, 2021

News Conference News EAS 2021

Lp(a) Not Associated With Ongoing Aortic Valve Calcification

Michael O'Riordan

June 04, 2021

News Daily News

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

L.A. McKeown

June 04, 2021

News Conference News EAS 2021

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

Michael O'Riordan

June 03, 2021

News Daily News

AHA: Physical Activity Should First-line Therapy as BP, LDL Tick Upwards

Michael O'Riordan

June 02, 2021

News Conference News ACC 2021

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Conference News EHRA 2021

RACE 3: Effects Wane for Targeted Therapy in Early AF, HF

Todd Neale

April 26, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2021

Shelley Wood

April 02, 2021

News Daily News

Study Suggests Periodontitis May Be a Marker of Hypertension

L.A. McKeown

March 29, 2021

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

News Daily News

FDA Approves Evinacumab for Rare Homozygous FH

Michael O'Riordan

February 11, 2021

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Michael O'Riordan

January 14, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2020

Shelley Wood

December 31, 2020

News Opinion Editor's Corner

The Biggest News of 2020: TCTMD’s Top 10

Shelley Wood

December 28, 2020

News Daily News

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

Shelley Wood

December 23, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

Advertisement

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

Lp(a) Not Associated With Ongoing Aortic Valve Calcification

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

AHA: Physical Activity Should First-line Therapy as BP, LDL Tick Upwards

Evinacumab Lowers Triglycerides in Severe Hypertriglyceridemia

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

RACE 3: Effects Wane for Targeted Therapy in Early AF, HF

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

TCTMD’s Top 10 Most Popular Stories for March 2021

Study Suggests Periodontitis May Be a Marker of Hypertension

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

FDA Approves Evinacumab for Rare Homozygous FH

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

TCTMD’s Top 10 Most Popular Stories for December 2020

The Biggest News of 2020: TCTMD’s Top 10

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Inclisiran Approved in Europe for Lowering LDL Cholesterol

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content